So President Trump has made this a priority, and we have. In addition to the 325 billion that we're putting into it, there's also a million that we're putting into it. President Trump is putting billions in from the tariffs, and we have secured agreements during the MFN negotiations with these companies to build billions and billions of dollars of plants right here in the United States. I think Lilly alone is building six new plants. Pfizer's building plans, all the big companies are now building here in the United States. (01:29–01:43)
CLAIM
Asserts that tariff funds and MFN negotiations are being used to build pharmaceutical plants in the U.S.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
